DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics (“DTx”) market, will be joining the broad-market Russell 3000(R) Index and the small-cap Russell 2000(R) Index at the conclusion of the Russell U.S. Indexes annual reconstitution, which will be effective after the U.S. equity markets open on Monday, June 28, 2021, according to a preliminary list of additions posted by FTSE Russell … Continue reading “BioMedNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Addition to Russell 2000, 3000 Indexes”
DarioHealth (NASDAQ: DRIO) president and North America general manager Rick Anderson will present at this year’s Vatican conference; the conference will be virtual this year. The Vatican’s Pontifical Council for Culture and the Cura Foundation’s Fifth International Vatican Conference is designed to globally advance human health by bringing together physicians, scientists, patient advocates, policy makers and … Continue reading “BioMedNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) President to Present, Participate at Fifth International Vatican Conference”
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, is partnering with MediOrbis, a telehealth provider specializing in chronic conditions, to provide remote patient monitoring services to Medicare patients with diabetes. The new virtual care initiative means that Medicare patients who have diabetes and who are eligible can receive convenient virtual care that … Continue reading “BioMedNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Partnership to Offer Virtual Care for Patients with Diabetes”
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has released its financial and business update report for the fourth quarter and full year 2020. The company reports significant progress across all aspects of its long-term strategic operating plan, including securing several accounts in the B2B (“B2B”) channel that are generating revenue and … Continue reading “BioMedNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports Q4, FY 2020 Numbers, Business Highlights”
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics (“DTx”) market, has been selected to participate in the virtual Stephens 2021 Best Ideas Conference. The conference is slated for March 11, 2021. As part of that participation, Dario CEO Erez Raphael and president/general manager Rick Anderson will presenting. Their presentation is scheduled to begin at 9 a.m. … Continue reading “BioMedNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Participate in Upcoming Stephens Best Ideas Conference”
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has announced the results of a new clinical study that examined the connection between personalization and sustained behavior change in digital health. The study indicates increased digital engagement resulted in 43% improvement in blood glucose levels. The study results were compiled in a paper … Continue reading “BioMedNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Results of New Clinical Study Showing Value of Personalization”
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital-therapeutics (“DTx”) market, today announced the company’s plans to participate in the upcoming Cowen 41st Annual Health Care Conference, a virtual event taking place March 1-4, 2021. According to the update, Dario’s CEO, Erez Raphael and Rick Anderson, president and general manager for North America, are scheduled … Continue reading “BioMedNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Present at Cowen 41st Annual Health Care Conference”
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has announced that CEO Erez Raphael will be participating in the upcoming SVB Leerink Global Healthcare Conference. The 10th annual SVB Leerink Healthcare Conference will be held Feb. 24–26, 2021. Raphael will participate in the premiere event and is also scheduled to host investor … Continue reading “BioMedNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) CEO Slated to Host Investor Meetings at Global Healthcare Conference”
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced that it has entered into a definitive agreement to acquire Upright Technologies Ltd., a digital musculoskeletal (“MSK”) company; the acquisition will be in the form of a stock transaction. The acquisition is designed to expand DarioHealth’s multi-condition platform into the $213 billion musculoskeletal … Continue reading “BioMedNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs Agreements to Acquire Leading Digital Musculoskeletal Company, Raise $70 Million Through Private Placement”
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced the appointment of two renowned experts to its Scientific Advisory Board (“SAB”). Dr. Marilyn Ritholz, psychologist at Joslin Diabetes Center, a Harvard Medical School affiliate, and Dr. David Horwitz, former global chief medical officer of Johnson & Johnson Diabetes Institute, join SAB chairman … Continue reading “BioMedNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Appoints Diabetes, Behavioral Health Experts to Scientific Advisory Board”
